Pretransplant cancer in kidney recipients in relation to recurrent and de novo cancer incidence posttransplantation and implications for graft and patient survival
Background.Whether kidney transplant recipients who were treated for a malignant tumor before transplantation are at an increased risk of developing a tumor posttransplantation has not been adequately quantified and characterized.Methods.We studied more than 270 000 patients on whom pretransplant an
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
March 2019
|
| In: |
Transplantation
Year: 2019, Jahrgang: 103, Heft: 3, Pages: 581-587 |
| ISSN: | 1534-6080 |
| DOI: | 10.1097/TP.0000000000002459 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/TP.0000000000002459 Verlag, lizenzpflichtig, Volltext: insights.ovid.com |
| Verfasserangaben: | Christian Unterrainer, Gerhard Opelz, Bernd Döhler, Caner Süsal |
| Zusammenfassung: | Background.Whether kidney transplant recipients who were treated for a malignant tumor before transplantation are at an increased risk of developing a tumor posttransplantation has not been adequately quantified and characterized.Methods.We studied more than 270 000 patients on whom pretransplant an |
|---|---|
| Beschreibung: | Gesehen am 09.03.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1534-6080 |
| DOI: | 10.1097/TP.0000000000002459 |